Medical Staff Pulse Newsletter

P&T Panel Changes Formulary; FDA Issues Warning About Olmesartan Medoxomil

Pharmacy Focus

June decisions by the Pharmacy and Therapeutics Committee include several changes to the formulary. Also, the U.S. Food and Drug Administration is warning that the blood pressure drug olmesartan medoxomil can cause intestinal problems known as sprue-like enteropathy.

» Read more

Meetings and Events

Grand Rounds

Click here to view upcoming grand rounds.

Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

Medical Staff CME Newsletter - July 2013 (PDF)

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

U.S. News & World Report, Best Hospitals 2013-14

A Message From Thomas M. Priselac, President and CEO

I would like to let you know that Cedars-Sinai has been named to the "Honor Roll" and is nationally ranked in 12 specialties in the U.S. News & World Report "Best Hospitals 2013-14" rankings, which were released Tuesday. While it is a very positive recognition of the tremendous work of everyone at Cedars-Sinai, and certainly a source of pride, it is important to keep some of these rankings, including the U.S. News one, in proper perspective. Our outstanding rankings this year in U.S. News provide a particularly meaningful time to make this point.

As you know, over the past several years there has been a proliferation of "rankings" and "scorecards" of hospitals, covering such areas as quality, reputation and clinical outcomes. At Cedars-Sinai, we carefully review the methodology of these rankings to determine which ones provide a meaningful measurement of our progress toward fulfilling our institutional mission and strategic goals, as some of these "rankings" have significant flaws in their methodology. If we place undue focus on external rankings instead of on other metrics that are a more accurate and meaningful measure of our progress in fulfilling our mission, we risk becoming distracted from our mission of serving our community, the nation and the world with outstanding clinical care, research, educational programs and community service.

Over the past several years, there has been increasing skepticism nationally of the U.S. News hospital rankings, based on peer-reviewed analyses highlighting some of the weaknesses in the methodology. Other studies showed that U.S. News rankings did not always correlate with widely accepted rankings on hospital safety and quality, such as the federal Hospital Compare website. In addition, consumer research has shown that rankings such as U.S. News have less influence on consumer decisions than had previously been thought.

At Cedars-Sinai, we have rigorous metrics in place to assess our quality, efficiency and effectiveness in patient care, research, education and community benefit. We will continue to focus on those metrics to not only help us assess our performance, but more importantly to help us continually improve. One of the hallmarks of our institution and the people who work and practice here is that even though we operate at the highest levels, we are always looking for ways to improve on that excellence.

Although it is not the primary focus for how we measure our progress, the below U.S. News rankings are nonetheless one of many recognitions for your outstanding work. In addition to being named to the national Honor Roll (#13 among all U.S. hospitals), here are specialty rankings:

  • Cancer (#26)
  • Cardiology and Heart Surgery (#9)
  • Diabetes and Endocrinology (#14)
  • Ear, Nose and Throat (#29)
  • Gastroenterology and GI Surgery (#5)
  • Geriatrics (#23)
  • Gynecology (#12)
  • Nephrology (#22)
  • Neurology and Neurosurgery (#14)
  • Orthopedics (#9)
  • Pulmonology (#20)
  • Urology (#10)

Everyone involved with Cedars-Sinai can be proud of our numerous national accolades. Each one of you, in many different ways, contributes to the excellence in Cedars-Sinai's clinical, research, teaching and community benefit programs. Thank you for your continued commitment to our mission, to our patients and to our community.